Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes MellitusYoshihiko Saito, Takeshi Morimoto, Sadanori Okada et al.|Circulation|2016Cited by 141
Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart FailureToshio Nishikimi, Kazuwa Nakao, Hiroyuki Okamoto et al.|PLoS ONE|2013Cited by 64
Effects of cardiotrophin-1 on hemodynamics and endocrine function of the heartIchiro Hamanaka, Kazuwa Nakao, Yoshihiko Saito et al.|American Journal of Physiology-Heart and Circulatory Physiology|2000Cited by 35
Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent DiabetesHisao Ogawa, Hirotaka Watada, Seigo Sugiyama et al.|Circulation Journal|2014Cited by 26
Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled TrialSadanori Okada, Masanori Kamura, Takeshi Morimoto et al.|Diabetes Care|2018Cited by 24